NMRA vs WMT · $283.5M cap vs P/E 42, rev $713.16B
Neumora Therapeutics, Inc. (NMRA) versus Walmart Inc (WMT) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Walmart Inc (WMT) is a discount stores company listed on US. It is led by Doug McMillon.
NMRA does not have a complete income-statement cache yet.
Latest reported WMT revenue for 2026-01-31 was $713.16B. Net income was $21.89B. Revenue was up 4.7% from 2025-01-31 to 2026-01-31. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
NMRA currently screens at market cap $283.5M. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
Not investment advice. Open the NMRA and WMT stock pages for the full models.
Not investment advice.